163 related articles for article (PubMed ID: 29656854)
1. Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes.
Reichard CA; Gregg JR; Achim MF; Aparicio AM; Pettaway CA; Pisters LL; Ward JF; Davis JW; Chapin BF
Eur Urol; 2018 Aug; 74(2):140-143. PubMed ID: 29656854
[TBL] [Abstract][Full Text] [Related]
2. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
Kodama H; Koie T; Oikawa M; Narita T; Tanaka T; Noro D; Iwamura H; Tobisawa Y; Yoneyama T; Hashimoto Y; Ohyama C
Int Urol Nephrol; 2020 Apr; 52(4):671-679. PubMed ID: 31897875
[TBL] [Abstract][Full Text] [Related]
3. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
Lavaud P; Gravis G; Foulon S; Joly F; Oudard S; Priou F; Latorzeff I; Mourey L; Soulié M; Delva R; Krakowski I; Laguerre B; Théodore C; Ferrero JM; Beuzeboc P; Habibian M; Rolland F; Deplanque G; Pouessel D; Zanetta S; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Tubiana-Mathieu N; Machiels JP; Kouri CE; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Culine S; Boher JM; Tergemina-Clain G; Legoupil C; Fizazi K
Eur Urol; 2018 May; 73(5):696-703. PubMed ID: 29074061
[TBL] [Abstract][Full Text] [Related]
5. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study.
Cindolo L; Natoli C; De Nunzio C; De Tursi M; Valeriani M; Giacinti S; Micali S; Rizzo M; Bianchi G; Martorana E; Scarcia M; Ludovico GM; Bove P; Laudisi A; Selvaggio O; Carrieri G; Bada M; Castellan P; Boccasile S; Ditonno P; Chiodini P; Verze P; Mirone V; Schips L
BMC Cancer; 2017 Nov; 17(1):753. PubMed ID: 29126389
[TBL] [Abstract][Full Text] [Related]
7. Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T; Berg KD; Røder MA; Brasso K; Iversen P; Huland H; Tiebel A; Schlomm T; Haese A; Salomon G; Budäus L; Tilki D; Heinzer H; Graefen M; Mandel P
Eur Urol Focus; 2017 Dec; 3(6):646-649. PubMed ID: 28753877
[TBL] [Abstract][Full Text] [Related]
8. Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
Pompe RS; Tian Z; Preisser F; Tennstedt P; Beyer B; Michl U; Graefen M; Huland H; Karakiewicz PI; Tilki D
Eur Urol Focus; 2017 Dec; 3(6):615-620. PubMed ID: 28869202
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
10. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
Patel DN; Jha S; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Chapin BF; Freedland SJ
Int J Urol; 2018 Dec; 25(12):998-1004. PubMed ID: 30253446
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in men with metastatic castration-resistant prostate cancer.
Gee A; Challapalli A; Bahl A
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):941-9. PubMed ID: 26512743
[TBL] [Abstract][Full Text] [Related]
12. Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.
Frantellizzi V; Costa R; Mascia M; Spanu A; Farcomeni A; Licari M; Cindolo L; Nuvoli S; Pontico M; De Vincentis G
Clin Genitourin Cancer; 2020 Jun; 18(3):185-191. PubMed ID: 32173355
[TBL] [Abstract][Full Text] [Related]
13. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
Sooriakumaran P; Karnes J; Stief C; Copsey B; Montorsi F; Hammerer P; Beyer B; Moschini M; Gratzke C; Steuber T; Suardi N; Briganti A; Manka L; Nyberg T; Dutton SJ; Wiklund P; Graefen M
Eur Urol; 2016 May; 69(5):788-94. PubMed ID: 26038098
[TBL] [Abstract][Full Text] [Related]
14. The role of palliative surgery in castration-resistant prostate cancer.
Piper C; Porres D; Pfister D; Heidenreich A
Curr Opin Support Palliat Care; 2014 Sep; 8(3):250-7. PubMed ID: 25090289
[TBL] [Abstract][Full Text] [Related]
15. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
16. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
[TBL] [Abstract][Full Text] [Related]
17. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
Heidenreich A; Pfister D; Brehmer B; Porres D
Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
[TBL] [Abstract][Full Text] [Related]
18. Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
Nik-Ahd F; Howard LE; Eisenberg AT; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
Cancer; 2019 Aug; 125(16):2861-2867. PubMed ID: 31034601
[TBL] [Abstract][Full Text] [Related]
19. Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer.
Heidenreich A; Bludau M; Bruns C; Nestler T; Porres D; Pfister DJKP
BJU Int; 2020 Sep; 126(3):342-349. PubMed ID: 32320130
[TBL] [Abstract][Full Text] [Related]
20. The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial.
Punnen S; Nahar B; Prakash NS; Sjoberg DD; Zappala SM; Parekh DJ
Eur Urol Focus; 2017 Feb; 3(1):94-99. PubMed ID: 28720374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
